Advanced Search
Twitter Linked In facebook button


Welcome to 3D-NET


 Drug Discovery and Development of Novel Eye Therapeutics  

3D net logo

There is an unmet clinical need for more effective treatments to halt or reverse eye diseases that lead to blindness (like age-related macular degeneration, diabetic retinopathy, and corneal inflammation) with increasing prevalence as the EU population ages.

3D-NET establishes a European network of industry and academic partners, who exchange knowledge, people, and expertise to enhance the discovery and development of drugs that target these ocular pathologies (Funded by a FP7- Marie Curie IAPP grant). This 4 year project was initiated in September 2013.

Coinciding with our first year general meeting we organized a workshop on “Drug Discovery and Ocular Therapy” (Valladolid, 23/09/2014), at which members of the consortium, external researchers, students and patients got together to learn from each other (read more)

The Mid Term Review Meeting of our project was celebrated on Friday 5th of June, 2015 in Dublin, hosted by the coordinator Dr Breandan Kennedy in UCD (Conway Institute). The Meeting turned out to be a really enjoyable experience with excellent presentations by fellows and partners, interesting posters and truly constructive discussions. Our project officer has confirmed that 3D-NET has successfully passed the Mid Term Review, and will therefore remain funded for the next 2 years, until at least August 2017 (read more)

Go to our News and Vacancies


 New announcement:

New Frontiers in Ocular Therapeutics Workshop

International Workshop in Dublin, UCD, Conway Institute (12-13 October 2015)

Go to NFOT Workshop Website

Registration open



Facebook 3D Net   3D-NET on Twitter‌   3D Net Linked In Group‌  

Like, follow, join us


Funded by the Marie Curie Industry-Academia Partnerships and Pathways (IAPP)Funded by: Marie Curie Industry-Academia Partnerships and Pathways (IAPP)

[Project Number: 612218/3D-NET]